Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
AMSTERDAM, April 15 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announced today that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan Drug…